Prevalence of oral mucosal lesions in human immunodeficiency virus-infected children attending the Pediatric Infectious Diseases Clinic in Cape Town by Mulder, Riaan et al.
OR I G I N A L A R T I C L E
Prevalence of oral mucosal lesions in human immunodeficiency
virus-infected children attending the Pediatric Infectious
Diseases Clinic in Cape Town
Riaan Mulder1 | Nadia Mohamed2 | Olorato Mathiba2
1Restorative Dentistry, The University of the
Western Cape, Cape Town, South Africa
2Pediatric Dentistry, The University of the
Western Cape, Cape Town, South Africa
Correspondence
Riaan Mulder, Restorative Dentistry, The
University of the Western Cape, Office 2015
C-floor, UWC dental faculty, Fransie van Zijl
Drive, Parow 7505, Cape Town, South Africa.
Email: rmulder@uwc.ac.za
Abstract
Objective: Investigation of the prevalence of oral mucosal lesions in human immuno-
deficiency virus (HIV)-infected children undergoing highly active antiretroviral ther-
apy (HAART).
Materials and Methods: Cross-sectional study of 66 HIV seropositive children, com-
prised of 28 (42.4%) females and 38 (57.6%) males (average age of 6 years). Study
participants all required data regarding CD4+ T-helper cell counts and the viral load.
All participants underwent an orofacial clinical examination by calibrated clinicians.
Associations between the presence of oral mucosal lesions, CD4+ cell counts, and
viral load were analyzed using Poisson regression.
Results: The prevalence of oral manifestations was detected in 21 children (31.8%).
Oral lesions were detected in 16 children with viral load copies <50 cells/mm3 and
22 children with CD4+ counts >500 cells/mm3. Predominant lesions identified
included angular cheilitis (36.7%), candidiasis (13.3%) and atypical oral ulcers (13.3%).
The presence of one lesion was the most prevalent represented by 19 children. Oral
lesions in relation to the CD4+ counts >500 resulted in; 14 children with one oral
lesion, 5 with two lesions and 3 with three oral mucosal lesions. The other half of this
CD4+ count patient group presented with no oral mucosal lesions. Oral lesions in
relation Viral load copies <50 resulted in; 9 children with one oral lesion, 3 with two
oral mucosal lesions and 4 with three oral mucosal lesions. The other half of this Viral
load patient group presented with no oral mucosal lesions. No significant correlations
were established between the presence of oral mucosal lesions and low CD4+
counts (p = 0.715) nor with high viral load counts (p = 0.638).
Conclusion: HIV-related oral mucosal lesions still presented in the participants
despite management with HAART. Based on the results, CD4+ counts and viral load
does not appear to be suitable markers of orofacial involvement in children.
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1 | INTRODUCTION
Human immunodeficiency virus (HIV) infections are characterized by
suppressed immune systems. The virus targets CD4+ T-helper cells
(CD4+ cells) in the immune system, which are meant to assist the
body in fighting infections. The virus replicates within these CD4+
cells until it eventually destroys them (Calles, Evans, &
Terlonge, 2010); this results in a decreased amount of CD4+ cells and
an increased viral load (Wilson et al., 2008). Globally, 160,000 new
HIV-infected children cases are recorded every year; this resulted in
940,000 children between the ages of 0 and 14 years receiving antire-
troviral therapy in 2018 (UNAIDS & Barton-Knott, 2019). The 2012
HIV/AIDS prevalence report, concerning South African children
between the ages of 0 and 14 years, stated that 1.25 million
children were infected out of a population of 52.8 million people
(Shisana et al., 2014). In 2017, the same age group represented 3 mil-
lion infected children out of a total South African population of 57 mil-
lion people (Simbayi et al., 2018). Furthermore, a South African study
recorded an oral lesion prevalence of 51.8% among children between
the ages of 0 and 14 years. Interestingly, the study's statistical analysis
found no association between age and the prevalence of oral mucosal
lesions (Duggal, Abudiak, Dunn, Tong, & Munyombwe, 2010). More-
over, several cardinal oral lesions are associated with the disease pro-
gression of HIV/AIDS, including oral candidiasis, hairy leukoplakia,
Kaposi sarcoma, linear gingival erythema, necrotizing ulcerative gingi-
vitis, necrotizing ulcerative periodontitis, and non-Hodgkin's lym-
phoma (NHL) (Coogan, Greenspan, & Challacombe, 2005). Oral
manifestations of HIV/AIDS are among the earliest signs of the dis-
ease and may function as markers of disease progression in both
adults and children (Coogan et al., 2005; Miziara & Weber, 2008).
Normal CD4+ cell counts for adolescents and adults range
between 500 and 1200 cells/mm3 (Bofill et al., 1992). Furthermore,
while infants and young children normally possess higher CD4+
counts than adolescents or adults, they slowly decline to adult values
by the age of 6 years (Shearer et al., 1997). Subsequently, this signifies
a need to consider age when dealing with the immunological status of
children, especially because the percentages of CD4+ cell counts are
imperative when determining the immunological staging in children.
The viral load is a blood test that determines the concentration of HIV
copies in a person's blood plasma and is expressed as copies/ml or as
a log10 value (Wilson et al., 2008). Clinicians use this test's results to
assess the severity of an infection. Ideally, the viral load of a patient
on antiretroviral medication should either remain undetectable or
manifest below the detection limit of 50 copies/ml (Doyle
et al., 2012). A rising viral load is often indicative of drug failure (Bofill
et al., 1992). This is alarming because a decrease in CD4+ cells and an
increased viral load make the body more susceptible to opportunistic
infections (Wilson et al., 2008; Yengopal, Bhayat, & Coogan, 2011).
Some of these infections result from commensal microorganisms that
take advantage of the immunosuppression and manifest as different
infections, including fungal, viral, and bacterial infections as well as
neoplastic lesions (Coogan et al., 2005; Yengopal et al., 2011). These
opportunistic infections often manifest in the oral cavity.
Nevertheless, the relevant literature asserts that a CD4+ count
on its own is not a reliable marker for HIV progression in pediatric
cases (Ramos-Gomez et al., 1996), which has led to the inclusion of
oral mucosal lesions. These oral mucosal lesions are determined in the
cited Table 1 of the reference article on orofacial lesions associated
with pediatric HIV infection (Ramos-Gomez et al., 1999). The inclusion
of oral mucosal lesions in the WHO clinical staging of HIV/AIDS has
significantly benefited developing countries, especially those with
poor resource settings where access to laboratory services is limited
and turnaround times for blood tests are longer than usual (Yengopal,
Kolisa, Thekiso, & Molete, 2016). Therefore, the presence of these
oral mucosal lesions acts as clinical signposts concerning the presence
and progression of a patients' immunodeficiency (Baghirath, Krishna,
Gannepalli, & Ali, 2013; Yengopal et al., 2016). Additionally, oral mani-
festations have been reported as the earliest indicative signs of a
pediatric HIV infection (Ramos-Gomez et al., 1999); therefore, they
aid in determining the prognosis and progression of an HIV infection
(Coogan et al., 2005). However, although the utilization of oral lesions
as predictors regarding the progression of HIV infections in adults has
been thoroughly investigated and documented, there is a dearth of
data concerning its efficacy in pediatric populations (dos Santos
Pinheiro et al., 2009; Meless et al., 2014; Oladokun, Okoje, Osinusi, &
Obimakinde, 2013; Rwenyonyi et al., 2011).
The oral health status and prevalence of oral mucosal lesions
among the children living with HIV/AIDS admitted to the Tygerberg
Pediatric Infectious Diseases Clinic (Tygerberg PIDC) were unknown
(Mohamed, Mathiba, & Mulder, 2020). This study aimed to investigate
the array of oral mucosal lesions associated with HIV among children
living with the disease.
2 | MATERIALS AND METHODS
The study was conducted at the Tygerberg PIDC, which conducts
antiretroviral therapy. It used a cross-sectional descriptive study
design in conjunction with the convenience sampling of candidates
who fit certain inclusion criteria. Participant inclusion criteria included
the following: children between the ages of 2 and 12 years with a
confirmed HIV-positive status; signed consent forms from legal guard-
ians; recorded viral loads or CD4+ count result records at the time of
the dental examination; and the ability to comply with a clinical exami-
nation conducted by the principal researcher (O. M.). An appropriate
sample size was determined with a power calculation, and 50 patients
were found to be adequately representative of the study population.
The clinical team consisted of two dentists; the calibration of the prin-
cipal researcher (O. M.) was conducted by the study leader (R. M.) and
exhibited a Cohen's kappa of 0.92.
A quantitative data collection process was employed for the
CD4+ counts and viral loads of the patients. The examinations
inspected the patients' facial, extra-oral, and intra-oral tissues and
included both an inspection and palpation of their mouths and facial
structures. The soft tissue oral lesions included in this study consisted
of the orofacial lesions that were outlined by the diagnostic criteria
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set out in the consensus classification of orofacial lesions associated
with pediatric HIV infection (Ramos-Gomez et al., 1999). To facilitate
the presumptive diagnoses of lesions, two references served as picto-
rial lesion comparisons: a visual reference chart for health care
workers (Wilson et al., 2008) and the reference consensus article
(Ramos-Gomez et al., 1999), which depicts common oral mucosal
lesions in children with HIV/AIDS.
The data were entered into a Microsoft Excel 2010 spreadsheet.
Subsequently, the statistical analysis was conducted using the R-
project program (Statistical analysis with R Core Team (2013); (R: A
language and environment for statistical computing. R Foundation for
Statistical Computing, Vienna, Austria).
Although the data distribution of the CD4+ counts and viral loads
was skewed, it was expected as it often occurs in HIV research.
Therefore, a statistical calculation was conducted to achieve an infor-
mative plot for the collected CD4+/viral load data transformation. A
natural log was used as the log of the statistically transformed vari-
ables of the CD4+ counts and the viral loads (Figure 1). The general-
ized linear models approach of the Poisson family was used to
determine the association between oral mucosal lesions with the
CD4+ counts (Figure 2) and oral mucosal lesions with viral load
(Figure 3) that the children exhibited. Additionally, frequency distribu-
tion was used to summarize and identify the children's most common
oral mucosal lesions and characteristics (Table 1).
The principal researcher (O. M.), who is a qualified dental practi-
tioner, performed a standardized clinical examination on all the partici-
pants. A basic examination pack was used for the examination of each
child; it consisted of an explorer probe, an intra-oral mirror, gauze, and
an LED headlight. All of the patients' oral mucosal lesions were
recorded, and a data capture sheet documented the information
obtained during the clinical assessment. The enrolled patients' data
capture sheets were kept safely in a locked cabinet in the Principal
Researcher's office.
Although children up to the age of 16 years are admitted to this
clinic, only children between 2 and 12 years of age—with a confirmed
HIV-positive status—were enrolled in the study because the upper
age limit for pediatric dental patients at the adjacent Tygerberg Oral
Health Centre is 12 years (Mohamed, Mathiba, & Mulder, 2020).
TABLE 1 The frequency distribution
of children according to their age, gender,
antiretroviral status, CD4+ cell count,
viral load, and number of mucosal lesions
Characteristics Number of children (% of children) Number of mucosal lesions
Gender 0 1 2 3
Male 38 (57.6%) 14 13 5 6
Female 28 (42.6%) 18 6 4 0
Age group (years)
2–6 34 (51.5%) 18 7 5 4
7–12 32 (48.5%) 14 12 4 2
Antiretroviral status
On HAART 63 (95.5%) 31 19 8 5
Not on HAART 3 (4.5%) 1 0 1 1
CD4+ count (cells/mm3)
Unknown 14 (21.2%) 6 4 3 1
<200 3 (4.5%) 2 0 1 0
200–500 5 (7.5%) 3 0 0 2
500 44 (66.6%) 22 14 5 3
Viral load (copies/ml)
<50 31 (47%) 15 9 3 4
50–1000 18 (27.3%) 10 6 2 0
1000–10,000 8 (12.1%) 4 1 3 0
>10,000 9 (13.6%) 4 2 1 2
F IGURE 1 Association between CD4+ count and viral load
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Regardless, following good clinical practice, brief oral health advice
was given to all the children and caregivers. Furthermore, participating
in the study was entirely voluntary, and participants were allowed to
withdraw at any time. The written consent forms were thoroughly
explained and issued to each participant's guardian. To maintain the
confidentiality of the participants' identities in this study, the patients'
names were not recorded in the data capture sheets. Instead, the
patients' medical record numbers were used for identification
purposes.
3 | RESULTS
From the 300 patients treated at Tygerberg PIDC, this study recruited
66 children; (28 [42.4%] females and 38 [57.6%] males; the M:F ratio
was 1.36:1) who complied with the inclusion criteria. Most partici-
pants (95.5%) were on highly active antiretroviral therapy (HAART).
Nearly half of the patients (n = 31) on HAART presented with no oral
mucosal lesions. The presence of one lesion was the most prevalent
represented by 19 children. When the oral lesions in relation to the
CD4+ counts >500 were considered; 14 children had one oral lesion,
5 children two lesions and 3 children presented with three oral muco-
sal lesions. The other half of this CD4+ count patient group presented
with no oral mucosal lesions. When the oral lesions in relation to the
Viral load copies <50 were considered; 9 children with one oral lesion,
3 with two oral mucosal lesions and 4 with three oral mucosal lesions.
The other half of this Viral load patient group presented with no oral
mucosal lesions. (Table 1). Ten of the patients presented with positive
diagnoses of Tuberculosis and eight had oral mucosal lesions. The
other co-morbidities could not be inferred of their additional influence
on the oral mucosal lesions as there was one patient per co-morbidity.
The recorded co-morbidities included diabetes, Down syndrome,
aplastic anemia, nephrotic syndrome, encephalitis, upper or lower
respiratory tract infections and cytomegalovirus.
Figure 1 displays a plotted graph of the square root of the CD4+
count versus the natural log of the Viral Load. According to this graph,
there is little to no correlation between the two variables; the Pearson
correlation coefficient between them was 0.264, p = 0.073. Fur-
thermore, the study compared the mean CD4+ counts and mean viral
loads between children with and without oral mucosal lesions. This
showed that, despite removing a clear outlier in the data, the correla-
tion coefficient between them was 0.232, p = 0.121. Consequently,
the difference between the children with oral mucosal lesions and the
children without oral mucosal lesions was not statistically significant;
that is, p = 0.701 and p = 0.176, respectively.
Figure 2 displays a plot concerning the number of lesions versus
the square root of the CD4+ count. By fitting a linear regression with
lesions designated as the dependent variable and CD4+ counts as the
predictor, it was revealed that the effects of the CD4+ counts were
not significant; p = 0.715. The generalized linear model approach,
family = Poisson, was used for this analysis. It clearly illustrated a lack
of correlation between the two variables. Notably, the lesion points
were slightly offset from the integer values to make all the observa-
tions visible.
Figure 3 displays a plotted graph concerning the number of
lesions versus the natural log of the viral load. The line on this graph
represents the fitted model; it employs the same technique used for
the lesions versus viral load comparison. The line's slope is not signifi-
cantly different from zero, indicating a non-significant association
between the two variables; p = 0.638.
The results concerning the various oral mucosal lesions illustrated
that Candidiasis infections were encountered most often, accounting
for 44.4%. Regarding the prevalence of the oral manifestations associ-
ated with HIV, 21 children (31.8%) presented with one or more oral
F IGURE 2 Association between the number of oral lesions and
CD4+ count
F IGURE 3 Association between the number of oral lesions and
viral load
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lesion (95% CI: 21.9–44.4), at the time of examination, predominantly
comprising of Angular cheilitis (n = 11; 36.7%), Candidiasis (n = 4;
13.3%) and Atypical oral ulcers (n = 4; 13.3%). 35 (53%) of the chil-
dren had mucosal lesions, with 19 (28.8%) presenting with one lesion.
Tables 2 and 3 display the relationships between various oral
mucosal lesions and the patients' CD4+ counts and viral loads respec-
tively. 66.6% of the lesions were present in children with CD4+
counts above 500 cells/mm3.
The oral lesion prevalence description omitted the inclusion of
cervical - or any other – lymphadenopathies to prevent the occur-
rence of bias. In total 24 children presented with lymphadenopathy
(36.4%) in this study and 9 exhibited other co-morbidities that also
result in cervical lymphadenopathies, such as cytomegalovirus infec-
tions (67%) and tuberculosis (15%). Similarly, a submental lymphade-
nopathy case in one patient could also be interpreted as bias. This
child suffered from concomitant ulcerative infections and multiple car-
ious teeth, which made it difficult to determine the exact cause of the
lymphadenopathy. Acute necrotizing ulcerative gingivitis (ANUG) and
acute necrotizing ulcerative periodontitis (ANUP) had a prevalence of
1.5%. Without definitive diagnostic aids to determine the exact diag-
nosis of the ulcer, a 6.1% prevalence of oral ulcerations was found in
this study. Herpes labialis and molluscum contagiosum were diag-
nosed in 4.5% of the patients and Herpes Simplex in 1.5%. One child
developed a NHL.
4 | DISCUSSION
A comprehensive oral examination is an important clinical assessment
tool for all oral health care workers. Evaluating oral soft tissue facili-
tates the recognition of oral mucosal lesions; this enables oral health
care workers to provide the appropriate treatments or recommend
further interventions and investigations geared toward proper diagno-
ses and treatments (Agbelusi & Wright, 2005). When targeted by a
comprehensive extra- and intra-oral examination, cervical lymphade-
nopathy is often detected in numerous patients. Studies that included
cervical lymphadenopathy as part of their prevalence percentage con-
cerning orofacial findings reported that the prevalence of “oral mani-
festations” ranged between 64% and 78% (Kaul, David, Savitha,
Rema, & Ramnarayan, 2009; Nabbanja, Gitta, Peterson, &
Rwenyonyi, 2013; Rwenyonyi et al., 2011). In this study, 36.4% of the
sample participants presented with lymphadenopathy. Therefore, it
was essential to exclude cervical lymphadenopathy from the preva-
lence percentage concerning oral mucosal lesions, as it is neither an
oral lesion nor is it included among the orofacial lesions determined
by Ramos-Gomez et al. (1999) that are associated with pediatric HIV
infection. Moreover, including cervical lymphadenopathy would have
skewed the oral mucosal lesions data in the literature (Kaul
et al., 2009; Nabbanja et al., 2013; Rwenyonyi et al., 2011). In this
study, several children that exhibited other co-morbidities that also
result in cervical lymphadenopathies, such as cytomegalovirus infec-
tions and tuberculosis, were evaluated to ensure no bias occurred.
Accordingly, the oral lesion prevalence description omitted the inclu-
sion of cervical—or any other—lymphadenopathy.
The prevalence of HIV-associated oral manifestations in children
varies significantly among resource-limited countries. The results from
this specific South African population exhibited a prevalence of oral
mucosal lesions (31.8%), which correlated well with the 31.4% preva-
lence in Brazil (Miziara & Weber, 2008). Conversely, several studies
reported low prevalence rates: 8.3% in West Africa (Meless
et al., 2014), 12.2% in Uganda (Rwenyonyi et al., 2011), and 13.3% in
Mozambique (Sales-Peres. et al., 2012). However, these findings are
considerably lower than those in studies where large numbers of the
participants were not on HAART medication, such as the following:











Pseudomembranous 2 (6.7) 0 0 1 (3.3)
Erythematous 0 1 (3.3) 0 0
Angular cheilitis 8 (26.7) 2 (6.7) 1 (3.3) 0
Parotid enlargement 0 0 0 1 (3.3)
Herpes labialis 3 (10) 0 0 0
Linear gingival
erythema
1 (3.3) 0 0 1 (3.3)
ANUG 1 (3.3) 0 0 0
Atypical oral ulcers 1 (3.3) 0 0 3 (10)
Molluscum
contagiosum
2 (6.7 0 0 1 (3.3)
Non-Hodgkin's
lymphoma
0 0 0 1 (3.3)
Total 18 (60) 3 (10) 1 (3.3) 8 (26.7)
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Tanzania (43.1%) (Hamza et al., 2006), Nigeria (41.7%) (Olaniyi &
Sunday, 2005), Uganda (48.9%) (Nabbanja et al., 2013), India (50%)
(Kaul et al., 2009), South Africa (51.8%) (Duggal et al., 2010), and in
Nigeria with 55.9% (Oladokun et al., 2013) and 61.9% (Adebola
et al., 2012).
Oral candidiasis is a good indicator of immune suppression and is,
therefore, commonly seen among patients who have progressed to
AIDS (Coogan et al., 2005; Gaitán-Cepeda et al., 2010;
Nittayananta, 2016). In this study, 40.9% of the children exhibited
some form of Candidiasis, while similar studies recorded a prevalence
of 22.5%–83.3% (Gaitán-Cepeda et al., 2014; Naidoo & Chikte, 2004;
Samaranayake, 1992). Although pseudomembranous candidiasis was
reported as the most prevalent variant among children, with values
ranging between 6% and 72% (Nabbanja et al., 2013; Oladokun
et al., 2013; Samaranayake, 1992), only 4.5% of this study's patients
presented with this variant.
While parotid enlargements are rarely seen in adults, parotid- and
other salivary gland enlargements are extremely common in children
with HIV infections (Ramos-Gomez et al., 1999); a study recorded a
prevalence ranging between 0% and 58% (Schiødt et al., 1992). The
recorded 1.5% prevalence of parotid enlargements found in this study is
analogous with the results of studies conducted in Tanzania, India,
Uganda, Nigeria, and West Africa (Hamza et al., 2006; Kaul et al., 2009;
Meless et al., 2014; Oladokun et al., 2013; Rwenyonyi et al., 2011).
The only child in this study who did present with a parotid
enlargement exhibited a high viral load. This finding correlates with
the conclusions of several studies that assert that HIV-associated
parotid enlargements occur late during the infection, thus signifying a
progression toward AIDS and immune failure (Jetpurwala &
Jain, 2012; Prabhu R. V., Prabhu, V., Chatra, L., & Shenai, P., 2013).
The prevalence of linear gingival erythema (LGE) in children with
HIV varies between different populations and can range anywhere
between 0% and 48% (Hamza et al., 2006; Kaul et al., 2009; Ramos-
Gomez et al., 1999; Rwenyonyi et al., 2011). In this study, 3% of the
patients had LGE and exhibited a viral load <50 copies/ml. Studies
have linked the occurrence of gingivitis and periodontal disease in
HIV-infected individuals to other relevant factors, such as poor oral
hygiene (dos Santos Pinheiro et al., 2009; Robinson, 2002). However,
several children had poor oral hygiene and increased dental plaque,
which made it diagnostically difficult to distinguish between LGE and
conventional gingivitis. The low result of 3% is peculiar, as other stud-
ies comparing the prevalence of LGE in HIV-infected and HIV-
negative participants found that LGE was not only equally common in
both groups but was significantly associated with dental plaque
in both groups as well (Grbic et al., 1995; Robinson, Sheiham,
Challacombe, Wren, & Zakrzewska, 1998). This disparity suggests that
LGE may be indistinguishable from conventional gingivitis, which
would explain the wide variability of its prevalence (Robinson, 2002).
Acute necrotizing ulcerative gingivitis (ANUG) and acute necrotiz-
ing ulcerative periodontitis (ANUP) are far less common in children,
with a low prevalence varying between 0.2% and 5% (Ramos-Gomez
et al., 1996; Ramos-Gomez et al., 1999; Ranganathan &
Hemalatha, 2006). Meless et al. (2014) found a prevalence of 1.7%
concerning these diseases, which corroborates the 1.5% prevalence
found in the patients of this study.
An atypical ulcerative lesion prevalence of 6% among outpatient
children in South Africa (Naidoo & Chikte, 2004) corroborated the
findings of this study. As ulcerative lesions often mimic each other, a
definitive diagnosis could not be reached. Therefore, this study encap-
sulated all ulcerative conditions together, except for recurrent
aphthous ulcers and herpes labialis (Naidoo & Chikte, 2004)—a form
of the Herpes Simplex Virus that exhibited a prevalence of 1.5%. Fur-
thermore, although this study did not find any recurrent aphthous
ulceration cases, several studies have reported a higher prevalence of











Pseudomembranous 0 2 (6.7) 0 1 (3.3)
Erythematous 0 0 0 1 (3.3)
Angular cheilitis 3 (10) 5 (16.7) 2 (6.7) 1 (3.3)
Parotid enlargement 0 0 1 (3.3) 0
Herpes labialis 2 (6.7) 1 (3.3) 0 0
Linear gingival
erythema
2 (6.7) 0 0 0
ANUG 0 1 (3.3) 0 0
Atypical oral ulcers 3 (10) 1 (3.3) 0 0
Molluscum
contagiosum
2 (6.7) 1 (3.3) 0 0
Non-Hodgkin's
lymphoma
0 0 0 1 (3.3)
Total 12 (40) 11 (36.7) 3 (10) 4 (13.3)
6 MULDER ET AL.
recurrent aphthous ulcerations that range between 0.4% and 14.1%
(Meless et al., 2014; Nabbanja et al., 2013; Oladokun et al., 2013;
Rwenyonyi et al., 2011). Additionally, several studies have reported
that the herpes simplex virus (HSV) infection prevalence among their
participants was between 1.7% and 24% (Bodhade, Ganvir, &
Hazarey, 2011; Flaitz & Hicks, 2003; Ramos-Gomez et al., 1999;
Rwenyonyi et al., 2011). In this study, 4.5% of the patients presented
with herpes labialis.
Molluscum contagiosum proved the most common lesion with a
prevalence of 4.5%. This is higher than the percentages observed in
other studies: 0.9% (Flaitz & Hicks, 2003) and 3% (Ranganathan
et al., 2006). This heightened prevalence maybe because most of
these children live in crowded households and institutions (Brown,
Janniger, Schwartz, & Silverberg, 2006; Naidoo & Chikte, 2004; Reyn-
olds, Holman, Yorita Christensen, Cheek, & Damon, 2009).
HIV-associated malignancies are generally uncommon in the pedi-
atric population (Davidson & Eley, 2010). Nonetheless, most studies
found Kaposi sarcoma (KS) to be the most common neoplastic lesion
(Hamza et al., 2006; Nabbanja et al., 2013; Oladokun et al., 2013).
However, in this study, one child (1.5%) had developed a NHL. This
child exhibited an extremely high viral load despite being on HAART
medication, thus signifying immune failure. NHL is usually only seen in
the late stages of AIDS where CD4+ counts are below 100 cells/mm3
(Bajpai & Pazare, 2010). In the current population, antiretroviral treat-
ments caused most patients to retain high CD4+ counts and low viral
loads. This may explain the low prevalence rate of NHL.
To assess the factors associated with the occurrence of oral
lesions among the patients, the level of their immunosuppression was
assessed. A study previously hypothesized that the presence of oral
lesions in patients with HIV coincides with a deterioration of their
immune status—a low CD4+ count and high viral load (Baghirath
et al., 2013). Therefore, a lower CD4+ count is expected to lead to a
predisposition for oral lesions (Adebola et al., 2012; Sales-Peres
et al., 2012). Additionally, a CD4+ count and viral load, although mea-
suring different aspects of immunity, should display an inverse corre-
lation (HIV i-base, 2016). Furthermore, several studies assert that a
CD4+ count functions better as an indicator of disease progression
than a viral load (Adebola et al., 2012; Bodhade et al., 2011;
Rwenyonyi et al., 2011; Sales-Peres et al., 2012). However, this study,
along with several others, found little to no correlations between the
presence of oral mucosal lesions and CD4+ counts or viral loads
(Nabbanja et al., 2013; Shah, 2006) thus, the lowered CD4+ count
was a poor predictor (Gaitán-Cepeda et al., 2010).
This is because the lesions they presented with (angular cheilitis,
herpes labialis, atypical ulcers, and Molluscum Contagiosum) are easily
treated with improved home care. This study observed children with a
viral load below 50 copies/ml doing well clinically and was properly
adhering to their HAART medication. Despite the proper HAART
observation, the children with a viral load below 50 copies/ml showed
oral mucosal lesions in 24.2%, with no oral mucosal lesions for the
other half. Congruently, the findings of this study are corroborated by
the type of oral mucosal lesions observed among HIV-positive
patients in Nigeria and their correlation with the patients' specific
clinical-stage, viral loads, and CD4+ counts (Oladokun et al., 2013).
Furthermore, a study exploring the factors influencing the distribution
of oral mucosal lesions in children with CD4+ counts below
500 cells/mm3 revealed that they had significantly more oral mucosal
lesions than those with CD4+ counts above 500 cells/mm3
(Rwenyonyi et al., 2011). Conversely, this study reports the same
number of patients with and without oral mucosal lesions for CD4+
counts above 500 cells/mm3 (Table 1). Additionally, another study
concerning South African children with HIV discovered an association
between viral loads and CD4+ counts with the presence of oral
mucosal lesions (Duggal et al., 2010). Therefore, the results of this
study verify other findings that state that oral mucosal lesions are
independently associated with immunosuppression (Meless
et al., 2014). Consequently, these findings suggest that CD4+ counts
and viral loads are not indicators of disease progression for children
between the ages of 2 and 12.
5 | CONCLUSION
Several oral manifestations of HIV were observed in a portion of the
study population despite the use of HAART medication; the most
common of these lesions were candidiasis infections (particularly
angular cheilitis). However, the presence of oral mucosal lesions was
not significantly correlated with the immunosuppression status of the
patients. Based on the results, CD4+ counts and viral load does not
appear to be suitable markers of orofacial involvement in children.
Nevertheless, the early recognition of oral mucosal lesions can still
facilitate appropriate and early interventions for collaborative health
platforms. This can only be accomplished through improved oral
screening and referral processes between health practitioners.
5.1 | Recommendations
This study highlights the need for oral health awareness and access to
oral health services for children living with HIV in South Africa. Most
of the patients' caregivers were unaware of services offered at
Tygerberg Dental Faculty, UWC, as well as the importance of manag-
ing oral mucosal lesions. Therefore, education programs and primary
health care screening programs should be implemented by the dental
faculty to drive this service.
The research data also stressed the need for a collaborative effort
between the PIDC and pediatric dental clinics to provide effective oral
health services for children living with HIV.
5.2 | Limitations of the study
A potential limitation of this study could be the small sample size at
the PIDC, since this clinic is located in one of the nine provinces of
South Africa. Larger sample sizes would have been more representa-
tive of the overall oral health status of children in South Africa.
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